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Interoffice Memorandum
SCHOOL OF PHARMACY
OFFICE OF THE DEAN
University, MS 38677
Phone: (662) 915-7265 Fax: (662) 915-5704
TO: All School of Pharmacy & USDA Personnel
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs
DATE: June 30, 2008
SUBJECT: Research News (#2)
The following GRANTS/CONTRACTS have recently been awarded:
1. Dr. Joseph Byrd (P.I. - Pharmacy Practice). Mississippi State Hospital and University of
Mississippi School of Pharmacy Agreement - FY 08-09 (Mississippi State Hospital), $24,000,
May 1, 2008-April 30, 2009.
2. Dr. Joseph Byrd (P.I. - Pharmacy Practice). University of Mississippi Medical
Center/University of Mississippi School of Pharmacy/Department of Pharmacy Practice
Agreement - FY 08-09 (UMMC, Department of Pediatrics), $23,575, July 1, 2008-June 30,
2009.
3. Dr. Stephen Cutler (P.I. - Medicinal Chemistry). Center for Excellence in Natural Products
Neuroscience - Year 3 (National Institutes of Health/National Center for Research Resources),
$1,967,642, July 1, 2008-June 30, 2009.
4. Dr. Mahmoud ElSohly (P.I. - NCNPR), and Dr. Ikhlas Khan (Co-P.I. - NCNPR).
Production, Analysis and Distribution of Cannabis, Marijuana Cigarettes and Related Materials
- Mod. No. 9 (National Institute on Drug Abuse), $260,910, March 15, 2005-March 14, 2010.
5. Dr. Mark Hamann (P.I. - Pharmacognosy) and Dr. Jiangnan Peng (Co-P.I. -
Pharmacognosy). Assessment of Supercritical CO2 Inactivation of Oyster Associated Bacteria
(Mississippi/Alabama Sea Grant Consortium/The University of Southern Mississippi/U.S.
Department of Commerce/National Oceanic and Atmospheric Administration), $14,996,
February 1, 2008-January 31, 2009.
6. Dr. Mark Hamann (P.I. - Pharmacognosy). The Isolation and Characterization of
Antimalarial Agents with Marine Micro-Organisms - No. 3 (Medicines for Malaria Venture),
$15,000, January 1, 2006-December 31, 2011.
7. Dr. Muhammad Ilias (P.I. - NCNPR), Dr. Babu Tekwani (Co-P.I. - NCNPR), and Dr.
Ikhlas Khan (Co-P.I. - NCNPR). Standardization of Banisteriopsis caapi for Chemical and
Biological Markers - Year 2 (National Institutes of Health), $211,680, May 1, 2008-April 30,
2009.
8. Dr. Thomas Lombardo (P.I. – Psychology/ORSP), Dr. John Bentley (Co-P.I. - Pharmacy
Administration), and Dr. Sandra Bentley (Co-P.I. - Pharmacy Practice). “ACT Now”
Tobacco Intervention Program – FY 08 (University of Mississippi Medical Center/State of
Mississippi), $5,000, May 1, 2008-June 30, 2008.
9. Dr. Michael Repka (P.I. – Pharmaceutics), and Dr. Soumyajit Majumdar (Co-P.I. -
Pharmaceutics). Equipment  for Center for Thermal Pharmaceutical Processing (Health
Resources and Services Administration), $284,030, June 1, 2008-September 30, 2010.
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10. Dr. Michael Repka (P.I. - Pharmaceutics), and Dr. Soumyajit Majumdar (Co-P.I. -
Pharmaceutics). Transmucosal Intra-Oral Drug Delivery Systems for THC (ElSohly
Laboratories, Inc./NIH, $189,654, June 1, 2008-May 31, 2009.
11. Dr. Ziaeddin Shariat-Madar (P.I. - Pharmacology). Evaluation of the Physiologic Effects of
FXia Inhibitors Possessing Plasma Kallikrein Activity (Pfizer, Inc.), $50,000, March 14, 2008-
March 13, 2009.
12. Dr. Marc Slattery (P.I. - Pharmacognosy), and Dr. Deborah Gochfeld (Co-P.I. - NCNPR).
New Ocean Resources: Exploration and Drug Discovery in the “Twilight Zone” (U.S.
Department of Commerce - National Oceanic and Atmospheric Administration), $23,230, May
1, 2008-April 30, 2009.
13. Dr. Robert Speth (P.I. - Pharmacology). Inhibition of Angiotensin II - Induced Cardiac
Fibrosis-Phase V (University of Florida), $4,500,  6/1/06-5/31/08.
14. Dr. Robert Speth (P.I. - Pharmacology). Summer Research Opportunities for Undergraduates
Program (Mississippi Functional Genomics Network/NIH), $1,000, May 14, 2008-August 15,
2008.
15. Dr. Noel Wilkin (P.I. - Research Institute for Pharmaceutical Services/Center for
Pharmaceutical Marketing and Management), Dr. William Lobb (Co-P.I. - RIPS/CPMM),
Dr. Benjamin Banahan (Co-P.I. - RIPS/CPMM). The Role and Value of Compounded
Prescription Medications (International Academy of Compounding Pharmacists), $15,003,
September 1, 2007-June 30, 2008.
16. Dr. Kristine Willett (P.I. - Pharmacology/Environmental Toxicology Research Program).
Coastal Health: Katrina (U.S. Dept. of Commerce, NOAA), Regrant - Increase Funding from
$57,024 to $83,527, October 1, 2006-September 30, 2011.
17. Dr. Kristine Willett (P.I. - Pharmacology). Roles of CYP1 & 19 in Fundulus Steroids &
PAH Metabolism (National Institute of Environmental Health Sciences), $220,178, May 1,
2008-April 30, 2009.
18. Dr. John Williamson (P.I. - Medicinal Chemistry). Mississippi Functional Genomics
Network (The University of Southern Mississippi/NIH), $86,400, May 1, 2008-April 30, 2009.
The following PUBLICATIONS have appeared:
1. Ameeta Agarwal, Tao Xu, Melissa Jacob, Qin Feng, Xing-Cong Li, Larry Walker, and
Alice Clark, “Genomic and Genetic Approaches for the Identification of Antifungal Drug
Targets”, Infectious Disorders – Drug Targets, 8, 2-15 (2008).
2. Ameeta Agarwal, Tao Xu, Melissa Jacob, Qin Feng, M.C. Lorenz, Larry Walker, and
Alice Clark, “Role of Heme in the Antifungal Activity of the Azaoxoaporphine Alkaloid
Sampangine”, Eukaryotic Cell, 7, 387-400 (2008).
3. V.K. Agnihotri, H.N. ElSohly, Shabana Khan, Troy Smillie, Ikhlas Khan, and Larry
Walker, “Antioxidant Constituents of Nymphaea caerulea Flowers”, Phytochemistry, (2008).
4. Zulfiqar Ali and Ikhlas Khan, “Alkaloids and Saponins from Blue Cohosh”,
Phytochemistry, 69, 1037-1042 (2008).
5. Zulfiqar Ali, Shabana Khan, and Ikhlas Khan, “New Cycloartane-Type Triterpene
Arabinosides from the Roots of Actaea podocarpa and their Biological Study”, Letter…
Planta Med, 73, 699-703 (2007).
6. Zulfiqar Ali, Daneel Ferreira, Paulo Carvalho, Mitchell Avery, and Ikhlas Khan,
“Nigellidine-4- O-Sulfite, the First Sulfated Indazole-Type Alkaloid from the Seeds of
Nigella” Journal of Natural Products 71, 1111-1112 (2008).
7. Zulfiqar Ali, F.R. Fronczek, and Ikhlas Khan, “Phenylalkanoids and Monoterpene
Analogues from the Roots of Rhodiola rosea”, Letter… Planta Med, 74, 178-181 (2008).
8. M. Aviram, N. Volkova, R. Coleman, M. Dreher, M.K. Reddy, Daneel Ferreira, and M.
Rosenblat, “Pomegranate Phenolics from the Peels, Arils, and Flowers are Antiatherogenic:
Studies in Vivo in Atherosclerotic Apolipoprotein E-Deficient (Eo) Mice and in Vitro in
Cultured Macrophages and Lipoproteins”, Journal of Agriculture and Food Chemistry, 56,
1148-1157 (2008).
9. K.M. Babu, Christopher McCurdy, and E.W. Boyer, “Opioid Receptors and Legal Highs:
Salvia divinorum and Kratom”,  Clinical Toxicology, 46, 146-152 (2008).
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10. Scott Baerson, Agnes Rimando, and Zhiqiang Pan, “Probing Allelochemical Biosynthesis
in Sorghum Root Hairs”, Plant Signaling & Behavior, 3, 1-4 (2008).
11. Scott Baerson, Franck Dayan, Agnes Rimando, Dhammika Nanayakkara, C.J. Liu, J.
Schroder, M. Fishbein, Zhiqiang Pan, I.A. Kagan, L.H. Pratt, M.M. Cordonnier-Pratt, and
Stephen Duke, “A Functional Genomics Investigation of Allelochemical Biosynthesis in
Sorghum bicolorRoot Hairs”, The Journal of Biological Chemistry, 283, 3231-3247 (2008).
12. R.V. Bikbulatov, J. Stewart, W. Jin, F. Yan, B.L. Roth, Daneel Ferreira, and Jordan
Zjawiony, “Short Synthesis of a Novel Class of Salvinorin A Analogs with Hemiacetalic
Structure”, Tetrahedron Letters, 49, 937-940 (2008).
13. P. Bissel, A. Khalil, John Rimoldi, K. Igarashi, D. Edmondson, A. Miller, and N. Castagnoli,
Jr., “Stereochemical Studies on the Novel Monoamine Oxidase B Substrates (1R,6S)- and
(1S,6R)-3-methyl-6-phenyl-3-aza-bicyclo[4.1.0]heptane”, Bioorganic & Medicinal Chemistry,
16, 3557-3564 (2008).
14. E.W. Boyer, K.M. Babu, Jessica Adkins, Christopher McCurdy, and J.H. Halpern, “Self-
Treatment of Chronic Pain and Opioid Withdrawal Using Kratom (Mitragynia speciosa
korth)”, Addiction, 103, 1048-1050 (2008).
15. Suvapun Bunniran, Erin Holmes, William Lobb, and David McCaffrey, “Ratings of
Journals for the Dissemination of Pharmacy-related Social and Administrative Science”,
Research in Social and Administrative Pharmacy, 4, 125-143 (2008).
16. S. Cheboyina, and Christy Wyandt, “Wax-Based Sustained Release Matrix Pellets Prepared
by a Novel Freeze Pelletization Technique – I. Formulation and Process Variables Affecting
Pellet Characteristics”, International Journal of Pharmaceutics, 359, 158-166 (2008).
17. S. Cheboyina, and Christy Wyandt, “Wax-Based Sustained Release Matrix pellets Prepared
by a Novel Freeze Pelletization Technique – II. In vitro Drug Release Studies and Release
Mechanisms”, International Journal of Pharmaceutics, 359, 166-173 (2008).
18. K.A. ElSayed, M.A. Khanfar, H.M. Shallal, A. Muralidharan, B. Awate, D.T.A. Youssef, Yang
Liu, Yu-Dong Zhou, Dale Nagle, and  G. Shah, “Latrunculin A and Its C-17-O-Carbamates
Inhibit Prostate Tumor Cell Invasion and HIF-1 Activation in Breast Tumor Cells”, Journal of
Natural Products, 71, 396-402 (2008).
19. A. Evidente, A. Cimmino, A. Andolfi, M. Vurro, M.C. Zonno, Charles Cantrell, and A. Motta,
“Phyllostictines A-D, Oxazatricycloalkenones Produced by Phyllosticta cirsii, A Potential
Mycoherbicide for Cirsium arvense Biocontrol”, Tetrahedron, 64, 1612-1619 (2008).
20. Deborah Gochfeld, C. Schloder, and R.W. Thacker, “Sponge Community Structure and
Disease Prevalence on Coral Reefs in Bocas del Toro, Panama”, Porifera Research:
Biodiversity, Innovation, and Sustainability, 335-343 (2007).
21. H.M.T. Bandara Herath, and N.P. Dhammika Nanayakkara, “Synthesis of
Enantiomerically Pure Fire Ant Venom Alkaloids: Solenopsins and Isosolenopsins A, B and
C”, Journal of Heterocyclic Chemistry, 45, 129-136 (2008).
22. W. Herath, Julie Mikell, A.L. Hale, Daneel Ferreira, and Ikhlas Khan, “Microbial
Metabolism Part 9.1) Structure and Antioxidant Significance of the Metabolites of 5,7-
Dihydroxyflavone (Chrysin), and 5- and 6-Hydroxyflavones”, Chem. Pharm. Bull., 56, 418-
422 (2008).
23. B.E. Kane, Christopher McCurdy, and D.M. Ferguson, “Towards a Structure-Based Model
of Salvinorin A Recognition of the k-Opioid Receptor”, Journal of Medicinal Chemistry, 51,
1824-1830 (2008).
24. Vardan Karamyan, and Robert Speth, “Animal Models of BMAA Neurotoxicity: A Critical
Review”, Life Sciences, 82, 233-246 (2008).
25. Soumyajit Majumdar, K. Hippalgaonkar, and Michael Repka, “Effect of Chitosan,
Benzalkonium Chloride and Ethylenediaminetetraacetic Acid on Permeation of Acyclovir
Across Isolated Rabbit Cornea”, International Journal of Pharmaceutics, 348, 175-178
(2008).
26. Christophe Mesangeau, Sanju Narayanan, A.M. Green, J. Shaikh, N. Kaushal, E. Viard,
Y.T. Xu, James Fishback, J.H. Poupaert, R.R. Matsumoto, and Christopher McCurdy,
“Conversion of a Highly Selective Sigma-1 Receptor-Ligand to Sigma-2 Receptor Preferring
Ligands with Anticocaine Activity”, Journal of Medicinal Chemistry, 51, 1482-1486 (2008).
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27. Cassia Mizuno, Guoyi Ma, Shabana Khan, A. Patny, Mitchell Avery, and Agnes
Rimando, “Design, Synthesis, Biological Evaluation and Docking Studies of Pterostilbene
Analogs Inside PPARµ”, Bioorganic & Medicinal Chemistry, 16, 3800-3808 (2008).
28. S.S. Murthy, V.S.R. Kiran, S.K. Mathur, and Narasimha Murthy, “Noninvasive
Transcutaneous Sampling of Glucose by Electroporation”, Journal of Diabetes Science and
Technology, 2, 250-254  (2008).
29. Narasimha Murthy, V.A. Boguda, and K. Payasada, “Electret Enhances Transdermal Drug
Permeation”, Biol. Pharm. Bull., 31, 99-102 (2008).
30. Narasimha Murthy, “Electroporatin and Transcutaneous Sampling (ETS) of Acyclovir”,
Journal of Dermatological Science, 49, 249-251 (2008).
31. Dhammika Nanayakkara, and Kevin Schrader, “Synthesis of Water-Soluble 9,10-
Anthraquinone Analogues with Potent Cyanobactericidal Activity toward the Musty-Odor
Cyanobacterium Oscillatoria perornata”, Journal of Agricultural and Food Chemistry, 56,
1002-1007 (2008).
32. Dhammika Nanayakkara, A.L. Ager, M.S. Bartlett, V. Yardley, S.L. Croft, Ikhlas Khan,
J.D. McChesney, and Larry Walker, “Antiparasitic Activities and Toxicities of Individual
Enantiomers of the 8-Aminoquinoline 8-[(4-Amino-1-Methylbutyl)Amino]-6-Methoxy-4-
Methyl-5-[3,4-Dichlorophenoxy]Quinoline Succinate—, Antimicrobial Agents and
Chemotherapy, 52, 2130-2137 (2008).
33. V.K. Nandula, K.N. Reddy, Agnes Rimando, Stephen Duke, and D.H. Poston,
“Glyphosate-Resistant and -Susceptible Soybean (Glycine max) and Canola (Brassica napus)
Dose Response and Metabolism Relationships with Glyphosate”, Journal of Agricultural and
Food Chemistry, 55, 3540-3545 (2008).
34. Zhiqiang Pan, Ameeta Agarwal, Tao Xu, Qin Feng, Scott Baerson, Stephen Duke, and
Agnes Rimando, “Identification of Molecular Pathways Affected by Pterostilbene, a Natural
Dimethylether Analog of Resveratrol”, BMC Medical Gemomics, 1 (2008).
35. Nirmal Pugh, H. Tamta, Premalatha Balachandran, X. Wu, J’Lynn Howell, Franck
Dayan, and David Pasco, “The Majority of in vitro Macrophage Activation Exhibited by
Extracts of Some Immune Enhancing Botanicals is Due to Bacterial Lipoproteins and
Lipopolysaccharides”, International Immunopharmacology, 8, 1023-1032 (2008).
36. Mohamed Radwan, Samir Ross, Desmond Slade, Safwat Ahmed, Fazila Zulfiqar, and
Mahmoud ElSohly, “Isolation and Characterization of New Cannabis Constituents from a
High Potency Variety”, Planta Med, 74, 267-272 (2008).
37. Ziyaur Rahman, K. Kohli, S.Q. Zhang, R.K. Khar, M. Ali, N.A. Charoo, M. Tauseef, A.A.
Shamsher, N.N. Mohammed, and Michael Repka, “In-Vivo Evaluation in Rats of Colon-
Specific Microspheres Containing 5-Fluorouracil”, Journal of Pharmacy and Pharmacology,
60, 615-623 (2008).
38. M.A. Rashid, V.U. Ahmad, M.A. Abbasi, Z. Ali, N. Rasool, M. Zubair, M.A. Lodhi, M.I.
Choudhary and Ikhlas Khan, “a-Chymotrypsin Inhibiting Benzylated Glycosides from
Symplocos racemosa”, Phytochemistry Letters, 1, 54-58 (2008).
39. Samir Ross, K. Krishnaven, Mohamed Radwan, S. Takamatsu, and Charles Burandt,
“Constituents of Zanthoxylum flavum and their Antioxidant and Antimalarial Activities”,
Natural Product Communications, 3, 791-794 (2008).
40. C.S. Satish, C. Kumar, Narasimha Murthy, and H.G. Shivakumar, “Biocompatibility Issues
of Implanted Polymeric Materials”, Indian Journal of Pharmaceutical Education and
Research, 41, 195-204 (2007).
41. H.N. Shivakumar, B.G. Desai, Narasimha Murthy, and Ashish Sharma, “The Disintegration
and Dissolution of Nabumetone Dispersible Tablets”, Pharmaceutical Technology, 60-68
(2007).
42. N. Singh, Tammy Nolan, and Christopher McCurdy, “Chemical Function-Based
Pharmacophore Development for Novel, Selective Kappa Opioid Receptor Agonists”, Journal
of Molecular Graphics and Modelling, (2008).
43. Robert Speth, and Vardan Karamyan, “The Significance of Brain Aminopeptidases in the
Regulation of the Actions of Angiotensin Peptides in the Brain”, Heart Fail Rev., 13, 299-309
(2008).
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44. A. Srivastava, Prasenjit Mukherjee, P.V. Desai, Mitchell Avery, and Babu Tekwani,
“Structural Analysis of Farnesyl Pyrophosphate Synthase from Parasitic Protozoa, a Potential
Chemotherapeutic Target”, Infectious Disorders - Drug Targets, 8, 16-30 (2008).
45. V.S. Tumuluri, M.S. Kemper, I.R. Lewis, S. Prodduturi, Soumyajit Majumdar, Bonnie
Avery, and Michael Repka, “Off-Line and On-Line Measurements of Drug-Loaded Hot-
Melt Extruded Films Using Raman Spectroscopy”, International Journal of Pharmaceutics,
357, 77-84, (2008).
46. H. Ueda, M.C. Hacker, A. Haesslein, Seongbong Jo, D.M. Ammon, R.N. Borazjani, J.F.
Kunzler, J. C. Salamone, and A.G. Mikos, “Injectable, in situ Forming Poly(propylene
fumarate)-Based Ocular Drug Delivery Systems”, Journal of Biomedical Materials Research
Part A, 656-666 (2007).
47. S.Q. Zhang, S. Thumma, G.H. Chen, W.B. Deng, Michael Repka, and S.M. Li, “In Vitro and
In Vivo Evaluation of Tegaserod Maleate pH-Dependent Tablets”, European Journal of
Pharmaceutics and Biopharmaceutics, 69, 247-254 (2008).
48. V.D. Zheljazkov, Charles Cantrell, W.B. Evans, M.W. Ebelhar, and C. Coker, “Yield and
Composition of Ocimum basilicum L. and Ocimum sanctum L. Grown at Four Locations”,
HortScience, 43, 737-741 (2008).
TECHNOLOGY TRANSFER transactions:
(In the interest of protecting confidential information, the names and titles associated with School
of Pharmacy invention disclosures and patent applications will no longer be published until after a
patent has issued.)
Research Disclosures Filed in FY2007-2008: 11
U. S. Patent Applications Pending:  26
Recent U. S. Patents Granted:! Novel Compounds and Methods for Inhibiting Cellular
Responses to Hypoxia; Zhou, Yu-Dong; Nagle, Dale; Mohammed, Asjad; Hossain,
Chowdhury. U.S. Patent # 7,375,132
The following SPECIAL ANNOUNCEMENTS are also listed:
• Dr. Michael A. Repka was:
(a) Invited Speaker, “Stabilization of actives in hot-melt extruded PEO films, APV
Experts’ Workshop on Hot-Melt Extrusion and its use in the manufacturing of
pharmaceutical dosage forms”, March 4-5, 2008 in Ludwigshafen, Germany.
(b) Invited Speaker and Chair of Plenary Sessions, “Evaluation of Buccal Delivery of _9-
Tetrahydrocannabinol Prodrugs Utilizing Hot-Melt Processed Oral Transmucosal Patch
Systems, 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical
Technology”, April 7-10, 2008 in Barcelona, Spain.
(c) Recently appointed to the Editorial Advisory Board of distinguished pharmaceutical
journals, AAPS PharmSciTech and Pharmaceutical Development and Technology.
Please continue to send me important research and graduate information so that I might share it
with your faculty colleagues.
This information is now being posted on the School of Pharmacy web page
(www.pharmacy.olemiss.edu).
cc: Dean Barbara G. Wells
Ms. Dabney Weems
Ms. Julie Edgington, Office of Research
